English

CYGENE LABORATORIES INC

EDGAR

Filing amendment (10KSB/A) · filed 2006-06-01

31 filing records in this dataset, filed from 1998-07-15 to 2006-06-01. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

11.3 thousand USD

2003-06-30 · USD

Exact inputs and evidence

Revenue: 11347 USD Source

Operating margin

-1,458.12%

2003-06-30 · %

Exact inputs and evidence

Operating Income: -165453 USD Source
Revenue: 11347 USD Source

Operating cash flow

-56.6 thousand USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -56598 USD Source

Free cash flow

-56.6 thousand USD

2003-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -56598 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 95.6 thousand USD 2005-03-31 Source
Exact value

95617 USD
Long-term debt including current maturities: 111 thousand USD 2005-03-31 Source
Exact value

111339 USD
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-3.7 million USD

2004-04-01 – 2005-03-31

Exact inputs and evidence

Net income: -702035 USD · 2004-04-01 – 2004-06-30 Source
Net income: -1113487 USD · 2004-07-01 – 2004-09-30 Source
Net income: -656607 USD · 2004-10-01 – 2004-12-31 Source
Net income: -3697127 USD · 2004-04-01 – 2005-03-31 Source
Net income: -2472131 USD · 2004-04-01 – 2004-12-31 Source

Operating cash flow

-1.4 million USD

2004-04-01 – 2005-03-31

Exact inputs and evidence

Operating cash flow: -441062 USD · 2004-04-01 – 2004-06-30 Source
Operating cash flow: -835340 USD · 2004-04-01 – 2004-09-30 Source
Operating cash flow: -441062 USD · 2004-04-01 – 2004-06-30 Source
Operating cash flow: -964891 USD · 2004-04-01 – 2004-12-31 Source
Operating cash flow: -835340 USD · 2004-04-01 – 2004-09-30 Source
Operating cash flow: -1397850 USD · 2004-04-01 – 2005-03-31 Source
Operating cash flow: -964891 USD · 2004-04-01 – 2004-12-31 Source

Capital expenditure

88.2 thousand USD

2004-01-01 – 2004-12-31

Exact inputs and evidence

Capital expenditure: 24828 USD · 2003-04-01 – 2004-03-31 Source
Capital expenditure: 21001 USD · 2003-04-01 – 2003-12-31 Source
Capital expenditure: 6965 USD · 2004-04-01 – 2004-06-30 Source
Capital expenditure: 16247 USD · 2004-04-01 – 2004-09-30 Source
Capital expenditure: 6965 USD · 2004-04-01 – 2004-06-30 Source
Capital expenditure: 84410 USD · 2004-04-01 – 2004-12-31 Source
Capital expenditure: 16247 USD · 2004-04-01 – 2004-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-06-01.

Financial data available through: 2005-03-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2002-03-31
Operating income: 10 of 11 periods available· newest 2005-03-31
Net income: 10 of 11 periods available· newest 2005-03-31
Operating cash flow: 10 of 11 periods available· newest 2005-03-31
Capital expenditure: 2 of 11 periods available· newest 2005-03-31
Total assets: 7 of 11 periods available· newest 2005-03-31
Total liabilities: 3 of 11 periods available· newest 2005-03-31
Current assets: 8 of 11 periods available· newest 2005-03-31
Current liabilities: 9 of 11 periods available· newest 2005-03-31
Cash and cash equivalents: 10 of 11 periods available· newest 2005-03-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2005-03-31
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 500,544

Prior period

−USD 3.2 million

2003-04-01 – 2004-03-31
Current period

−USD 3.7 million

2004-04-01 – 2005-03-31

Exact inputs and evidence

-3697127 − -3196583 = -500544 USD

-3196583 USD · 2003-04-01 – 2004-03-31
Inspect prior input Prior source
-3697127 USD · 2004-04-01 – 2005-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Year-over-year change in Net income: -500544 USD Concept: fundies:NetIncome Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3697127 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2811 Input fundies:NetIncome: -3196583 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2811
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 414,023

Prior period

−USD 983,827

2003-04-01 – 2004-03-31
Current period

−USD 1.4 million

2004-04-01 – 2005-03-31

Exact inputs and evidence

-1397850 − -983827 = -414023 USD

-983827 USD · 2003-04-01 – 2004-03-31
Inspect prior input Prior source
-1397850 USD · 2004-04-01 – 2005-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Year-over-year change in Operating cash flow: -414023 USD Concept: fundies:OperatingCashFlow Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1397850 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829 Input fundies:OperatingCashFlow: -983827 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+182.2%

Prior period

USD 24,828

2003-04-01 – 2004-03-31
Current period

USD 70,059

2004-04-01 – 2005-03-31

Exact inputs and evidence

70059 − 24828 = 45231 USD

24828 USD · 2003-04-01 – 2004-03-31
Inspect prior input Prior source
70059 USD · 2004-04-01 – 2005-03-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Year-over-year change in Capital expenditure: 45231 USD Concept: fundies:CapitalExpenditure Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 70059 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832 Input fundies:CapitalExpenditure: 24828 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2002 2001-04-01 – 2002-03-31

Revenue USD 13,951 100% of revenue
Operating costs Derived USD 19,672 141% of revenue
Operating income −USD 5,721 −41% of revenue
Tax, interest and other Derived −USD 3,136 −22% of revenue
Net income −USD 2,585 −19% of revenue

Cash

Operating cash flow USD 11,098 80% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Operating loss: operating costs were 112% of revenue.
1999 Operating loss: operating costs were 126% of revenue.
2000 36%62%
2001 Operating loss: operating costs were 351% of revenue.
2002 Operating loss: operating costs were 141% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1996 1995-04-01 – 1996-03-31	0	3454 Derived	-3454	-470 Derived	-2984	Unavailable	Source 1995-04-01 – 1996-03-31: 0 USD Inspect Revenue Open source 1995-04-01 – 1996-03-31: -3454 USD Inspect Operating Income Open source 1995-04-01 – 1996-03-31: -2984 USD Inspect Net Income Open source 1995-04-01 – 1996-03-31: -2184 USD Inspect Operating Cash Flow Open source
1997 1996-04-01 – 1997-03-31	0	2988 Derived	-2988	-501 Derived	-2487	Unavailable	Source 1996-04-01 – 1997-03-31: 0 USD Inspect Revenue Open source 1996-04-01 – 1997-03-31: -2988 USD Inspect Operating Income Open source 1996-04-01 – 1997-03-31: -2487 USD Inspect Net Income Open source 1996-04-01 – 1997-03-31: -1686 USD Inspect Operating Cash Flow Open source
1998 1997-04-01 – 1998-03-31	22917	25628 Derived	-2711	-60444 Derived	57733	Unavailable	Source 1997-04-01 – 1998-03-31: 22917 USD Inspect Revenue Open source 1997-04-01 – 1998-03-31: -2711 USD Inspect Operating Income Open source 1997-04-01 – 1998-03-31: 57733 USD Inspect Net Income Open source 1997-04-01 – 1998-03-31: 15784 USD Inspect Operating Cash Flow Open source
1999 1998-04-01 – 1999-03-31	47916	60142 Derived	-12226	1599 Derived	-13825	Unavailable	Source 1998-04-01 – 1999-03-31: 47916 USD Inspect Revenue Open source 1998-04-01 – 1999-03-31: -12226 USD Inspect Operating Income Open source 1998-04-01 – 1999-03-31: -13825 USD Inspect Net Income Open source 1998-04-01 – 1999-03-31: -31795 USD Inspect Operating Cash Flow Open source
2000 1999-04-01 – 2000-03-31	95833	59005 Derived	36828	2082 Derived	34746	Unavailable	Source 1999-04-01 – 2000-03-31: 95833 USD Inspect Revenue Open source 1999-04-01 – 2000-03-31: 36828 USD Inspect Operating Income Open source 1999-04-01 – 2000-03-31: 34746 USD Inspect Net Income Open source 1999-04-01 – 2000-03-31: 43306 USD Inspect Operating Cash Flow Open source
2001 2000-04-01 – 2001-03-31	8334	29225 Derived	-20891	-6648 Derived	-14243	Unavailable	Source 2000-04-01 – 2001-03-31: 8334 USD Inspect Revenue Open source 2000-04-01 – 2001-03-31: -20891 USD Inspect Operating Income Open source 2000-04-01 – 2001-03-31: -14243 USD Inspect Net Income Open source 2000-04-01 – 2001-03-31: -13345 USD Inspect Operating Cash Flow Open source
2002 2001-04-01 – 2002-03-31	13951	19672 Derived	-5721	-3136 Derived	-2585	Unavailable	Source 2001-04-01 – 2002-03-31: 13951 USD Inspect Revenue Open source 2001-04-01 – 2002-03-31: -5721 USD Inspect Operating Income Open source 2001-04-01 – 2002-03-31: -2585 USD Inspect Net Income Open source 2001-04-01 – 2002-03-31: 11098 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 14K 2002

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-03-31	Revenue	0	Revenue: 0 Open source
19971997-03-31	Revenue	0	Revenue: 0 Open source
19981998-03-31	Revenue	22917	Revenue: 22917 Open source
19991999-03-31	Revenue	47916	Revenue: 47916 Open source
20002000-03-31	Revenue	95833	Revenue: 95833 Open source
20012001-03-31	Revenue	8334	Revenue: 8334 Open source
20022002-03-31	Revenue	13951	Revenue: 13951 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

67.4% 2002

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19961996-03-31	Year over year	No prior comparable period	Revenue: 0 Open source
19971997-03-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19981998-03-31	Year over year	No prior comparable period	Revenue: 22917 Open source Revenue: 0 Open source
19991999-03-31	Year over year	109.1%	Revenue: 47916 Open source Revenue: 22917 Open source
20002000-03-31	Year over year	100%	Revenue: 95833 Open source Revenue: 47916 Open source
20012001-03-31	Year over year	-91.3%	Revenue: 8334 Open source Revenue: 95833 Open source
20022002-03-31	Year over year	67.4%	Revenue: 13951 Open source Revenue: 8334 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -41% 2002

Net margin -18.5% 2002

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19961996-03-31	Operating margin	Not reported	Operating Income: -3454 Open source Revenue: 0 Open source
19971997-03-31	Operating margin	Not reported	Operating Income: -2988 Open source Revenue: 0 Open source
19981998-03-31	Operating margin	-11.8%	Operating Income: -2711 Open source Revenue: 22917 Open source
19991999-03-31	Operating margin	-25.5%	Operating Income: -12226 Open source Revenue: 47916 Open source
20002000-03-31	Operating margin	38.4%	Operating Income: 36828 Open source Revenue: 95833 Open source
20012001-03-31	Operating margin	-250.7%	Operating Income: -20891 Open source Revenue: 8334 Open source
20022002-03-31	Operating margin	-41%	Operating Income: -5721 Open source Revenue: 13951 Open source
19961996-03-31	Net margin	Not reported	Net Income: -2984 Open source Revenue: 0 Open source
19971997-03-31	Net margin	Not reported	Net Income: -2487 Open source Revenue: 0 Open source
19981998-03-31	Net margin	251.9%	Net Income: 57733 Open source Revenue: 22917 Open source
19991999-03-31	Net margin	-28.9%	Net Income: -13825 Open source Revenue: 47916 Open source
20002000-03-31	Net margin	36.3%	Net Income: 34746 Open source Revenue: 95833 Open source
20012001-03-31	Net margin	-170.9%	Net Income: -14243 Open source Revenue: 8334 Open source
20022002-03-31	Net margin	-18.5%	Net Income: -2585 Open source Revenue: 13951 Open source
19961996-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2184 Open source
19971997-03-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1686 Open source
19981998-03-31	Free cash flow margin	Not reported	Revenue: 22917 Open source Operating Cash Flow: 15784 Open source
19991999-03-31	Free cash flow margin	Not reported	Revenue: 47916 Open source Operating Cash Flow: -31795 Open source
20002000-03-31	Free cash flow margin	Not reported	Revenue: 95833 Open source Operating Cash Flow: 43306 Open source
20012001-03-31	Free cash flow margin	Not reported	Revenue: 8334 Open source Operating Cash Flow: -13345 Open source
20022002-03-31	Free cash flow margin	Not reported	Revenue: 13951 Open source Operating Cash Flow: 11098 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 11.1K 2002

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-03-31	Operating cash flow	-2184	Operating Cash Flow: -2184 Open source
19971997-03-31	Operating cash flow	-1686	Operating Cash Flow: -1686 Open source
19981998-03-31	Operating cash flow	15784	Operating Cash Flow: 15784 Open source
19991999-03-31	Operating cash flow	-31795	Operating Cash Flow: -31795 Open source
20002000-03-31	Operating cash flow	43306	Operating Cash Flow: 43306 Open source
20012001-03-31	Operating cash flow	-13345	Operating Cash Flow: -13345 Open source
20022002-03-31	Operating cash flow	11098	Operating Cash Flow: 11098 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19961996-03-31	Free cash flow	Unavailable	Operating Cash Flow: -2184 Open source
19971997-03-31	Free cash flow	Unavailable	Operating Cash Flow: -1686 Open source
19981998-03-31	Free cash flow	Unavailable	Operating Cash Flow: 15784 Open source
19991999-03-31	Free cash flow	Unavailable	Operating Cash Flow: -31795 Open source
20002000-03-31	Free cash flow	Unavailable	Operating Cash Flow: 43306 Open source
20012001-03-31	Free cash flow	Unavailable	Operating Cash Flow: -13345 Open source
20022002-03-31	Free cash flow	Unavailable	Operating Cash Flow: 11098 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1996-03-31	Liabilities / assets	Not reported	No source recorded
1997-03-31	Liabilities / assets	Not reported	No source recorded
1998-03-31	Liabilities / assets	Not reported	Total Assets: 63758 Open source
1999-03-31	Liabilities / assets	Not reported	No source recorded
2000-03-31	Liabilities / assets	Not reported	Total Assets: 132292 Open source
2001-03-31	Liabilities / assets	Not reported	Total Assets: 129011 Open source
2002-03-31	Liabilities / assets	Not reported	Total Assets: 136866 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.83× 2002

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1996-03-31	Current assets / current liabilities	Not reported	No source recorded
1997-03-31	Current assets / current liabilities	Not reported	Current Liabilities: 136050 Open source
19981998-03-31	Current assets / current liabilities	1.26×	Current Assets: 46615 Open source Current Liabilities: 36955 Open source
19991999-03-31	Current assets / current liabilities	1.22×	Current Assets: 48153 Open source Current Liabilities: 39486 Open source
20002000-03-31	Current assets / current liabilities	2.47×	Current Assets: 132292 Open source Current Liabilities: 53568 Open source
20012001-03-31	Current assets / current liabilities	2×	Current Assets: 129011 Open source Current Liabilities: 64530 Open source
20022002-03-31	Current assets / current liabilities	1.83×	Current Assets: 136866 Open source Current Liabilities: 74970 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1995-04-01 – 1996-03-31	−USD 2,984 Exact value Exact value: -2984 USD 1995-04-01 – 1996-03-31: -2984 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 1996-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -2984 USD Concept: fundies:NetIncome Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2984 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-98-008420.txt#822 The citation records this snapshot. The page link may show a newer release later.	−USD 2,184 Exact value Exact value: -2184 USD 1995-04-01 – 1996-03-31: -2184 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 1996-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -2184 USD Concept: fundies:OperatingCashFlow Period: 1995-04-01 to 1996-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=1996-03-31&surface=latest&period_type=duration&start=1995-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2184 USD (1995-04-01 to 1996-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-98-008420.txt#834 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1997 1996-04-01 – 1997-03-31	−USD 2,487 Exact value Exact value: -2487 USD 1996-04-01 – 1997-03-31: -2487 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 1997-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -2487 USD Concept: fundies:NetIncome Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2487 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-98-008420.txt#822 The citation records this snapshot. The page link may show a newer release later.	−USD 1,686 Exact value Exact value: -1686 USD 1996-04-01 – 1997-03-31: -1686 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 1997-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -1686 USD Concept: fundies:OperatingCashFlow Period: 1996-04-01 to 1997-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=1997-03-31&surface=latest&period_type=duration&start=1996-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1686 USD (1996-04-01 to 1997-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-98-008420.txt#834 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1998 1997-04-01 – 1998-03-31	USD 57,733 Exact value Exact value: 57733 USD 1997-04-01 – 1998-03-31: 57733 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 1998-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: 57733 USD Concept: fundies:NetIncome Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:NetIncome: 57733 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-99-008895.txt#806 The citation records this snapshot. The page link may show a newer release later.	USD 15,784 Exact value Exact value: 15784 USD 1997-04-01 – 1998-03-31: 15784 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 1998-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: 15784 USD Concept: fundies:OperatingCashFlow Period: 1997-04-01 to 1998-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=1998-03-31&surface=latest&period_type=duration&start=1997-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 15784 USD (1997-04-01 to 1998-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-99-008895.txt#816 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
1999 1998-04-01 – 1999-03-31	−USD 13,825 Exact value Exact value: -13825 USD 1998-04-01 – 1999-03-31: -13825 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 1999-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -13825 USD Concept: fundies:NetIncome Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:NetIncome: -13825 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-00-008970.txt#911 The citation records this snapshot. The page link may show a newer release later.	−USD 31,795 Exact value Exact value: -31795 USD 1998-04-01 – 1999-03-31: -31795 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 1999-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -31795 USD Concept: fundies:OperatingCashFlow Period: 1998-04-01 to 1999-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=1999-03-31&surface=latest&period_type=duration&start=1998-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31795 USD (1998-04-01 to 1999-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-00-008970.txt#922 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2000 1999-04-01 – 2000-03-31	USD 34,746 Exact value Exact value: 34746 USD 1999-04-01 – 2000-03-31: 34746 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2000-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: 34746 USD Concept: fundies:NetIncome Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:NetIncome: 34746 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-01-505029.txt#970 The citation records this snapshot. The page link may show a newer release later.	USD 43,306 Exact value Exact value: 43306 USD 1999-04-01 – 2000-03-31: 43306 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2000-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: 43306 USD Concept: fundies:OperatingCashFlow Period: 1999-04-01 to 2000-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2000-03-31&surface=latest&period_type=duration&start=1999-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 43306 USD (1999-04-01 to 2000-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-01-505029.txt#982 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2001 2000-04-01 – 2001-03-31	−USD 14,243 Exact value Exact value: -14243 USD 2000-04-01 – 2001-03-31: -14243 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2001-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -14243 USD Concept: fundies:NetIncome Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2001-03-31&surface=latest&period_type=duration&start=2000-04-01&unit=USD&dimensions= Input fundies:NetIncome: -14243 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-02-007036.txt#931 The citation records this snapshot. The page link may show a newer release later.	−USD 13,345 Exact value Exact value: -13345 USD 2000-04-01 – 2001-03-31: -13345 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2001-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -13345 USD Concept: fundies:OperatingCashFlow Period: 2000-04-01 to 2001-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2001-03-31&surface=latest&period_type=duration&start=2000-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13345 USD (2000-04-01 to 2001-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0000950144-02-007036.txt#941 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2002 2001-04-01 – 2002-03-31	−USD 2,585 Exact value Exact value: -2585 USD 2001-04-01 – 2002-03-31: -2585 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2002-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -2585 USD Concept: fundies:NetIncome Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:NetIncome: -2585 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001164621-03-000163.txt#1125 The citation records this snapshot. The page link may show a newer release later.	USD 11,098 Exact value Exact value: 11098 USD 2001-04-01 – 2002-03-31: 11098 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2002-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: 11098 USD Concept: fundies:OperatingCashFlow Period: 2001-04-01 to 2002-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2002-03-31&surface=latest&period_type=duration&start=2001-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 11098 USD (2001-04-01 to 2002-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001164621-03-000163.txt#1137 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2002-04-01 – 2003-03-31	−USD 3.48 million Exact value Exact value: -3482982 USD 2002-04-01 – 2003-03-31: -3482982 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2003-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -3482982 USD Concept: fundies:NetIncome Period: 2002-04-01 to 2003-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2003-03-31&surface=latest&period_type=duration&start=2002-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3482982 USD (2002-04-01 to 2003-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-04-002808.txt#2007 The citation records this snapshot. The page link may show a newer release later.	−USD 20,990 Exact value Exact value: -20990 USD 2002-04-01 – 2003-03-31: -20990 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2003-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -20990 USD Concept: fundies:OperatingCashFlow Period: 2002-04-01 to 2003-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2003-03-31&surface=latest&period_type=duration&start=2002-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20990 USD (2002-04-01 to 2003-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001164621-03-000163.txt#1137 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2004 2003-04-01 – 2004-03-31	−USD 3.2 million Exact value Exact value: -3196583 USD 2003-04-01 – 2004-03-31: -3196583 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2004-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -3196583 USD Concept: fundies:NetIncome Period: 2003-04-01 to 2004-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2004-03-31&surface=latest&period_type=duration&start=2003-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3196583 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2811 The citation records this snapshot. The page link may show a newer release later.	−USD 983,827 Exact value Exact value: -983827 USD 2003-04-01 – 2004-03-31: -983827 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2004-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -983827 USD Concept: fundies:OperatingCashFlow Period: 2003-04-01 to 2004-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2004-03-31&surface=latest&period_type=duration&start=2003-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -983827 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829 The citation records this snapshot. The page link may show a newer release later.	USD 24,828 Exact value Exact value: 24828 USD 2003-04-01 – 2004-03-31: 24828 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYGENE LABORATORIES INC · 2004-03-31 CYGENE LABORATORIES INC (edgar:810691) Capital Expenditure: 24828 USD Concept: fundies:CapitalExpenditure Period: 2003-04-01 to 2004-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ACapitalExpenditure&period=2004-03-31&surface=latest&period_type=duration&start=2003-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 24828 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832 The citation records this snapshot. The page link may show a newer release later.	−USD 1.01 million Calculation and evidence -983827 − 24828 USD Exact free cash flow: -1008655 USD 2003-04-01 – 2004-03-31: -983827 USD · Inspect Operating Cash Flow · Source 2003-04-01 – 2004-03-31: 24828 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYGENE LABORATORIES INC · 2004-03-31 CYGENE LABORATORIES INC (edgar:810691) Free cash flow: -1008655 USD Concept: free-cash-flow Period: 2003-04-01 to 2004-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -983827 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829 Input fundies:CapitalExpenditure: 24828 USD (2003-04-01 to 2004-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832 The citation records this snapshot. The page link may show a newer release later.
2005 2004-04-01 – 2005-03-31	−USD 3.7 million Exact value Exact value: -3697127 USD 2004-04-01 – 2005-03-31: -3697127 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Net Income: -3697127 USD Concept: fundies:NetIncome Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ANetIncome&period=2005-03-31&surface=latest&period_type=duration&start=2004-04-01&unit=USD&dimensions= Input fundies:NetIncome: -3697127 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2811 The citation records this snapshot. The page link may show a newer release later.	−USD 1.4 million Exact value Exact value: -1397850 USD 2004-04-01 – 2005-03-31: -1397850 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Operating Cash Flow: -1397850 USD Concept: fundies:OperatingCashFlow Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3AOperatingCashFlow&period=2005-03-31&surface=latest&period_type=duration&start=2004-04-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1397850 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829 The citation records this snapshot. The page link may show a newer release later.	USD 70,059 Exact value Exact value: 70059 USD 2004-04-01 – 2005-03-31: 70059 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Capital Expenditure: 70059 USD Concept: fundies:CapitalExpenditure Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691/explain?concept=fundies%3ACapitalExpenditure&period=2005-03-31&surface=latest&period_type=duration&start=2004-04-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 70059 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832 The citation records this snapshot. The page link may show a newer release later.	−USD 1.47 million Calculation and evidence -1397850 − 70059 USD Exact free cash flow: -1467909 USD 2004-04-01 – 2005-03-31: -1397850 USD · Inspect Operating Cash Flow · Source 2004-04-01 – 2005-03-31: 70059 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYGENE LABORATORIES INC · 2005-03-31 CYGENE LABORATORIES INC (edgar:810691) Free cash flow: -1467909 USD Concept: free-cash-flow Period: 2004-04-01 to 2005-03-31 Values: Latest reported Published: 2026-11-03T00:00:32Z Snapshot: 08b4f34cb51fe8cf55782c77bcde87972b643890ec294b1117f4cf9ffb923ef3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/810691?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1397850 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2829 Input fundies:CapitalExpenditure: 70059 USD (2004-04-01 to 2005-03-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/810691/0001116502-06-001145.txt#2832 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-03. Source filing dates and reporting periods are shown separately.

Identifiers: 0000810691, 810691, edgar:810691

Also known as TRANSPIRATOR TECHNOLOGIES INC /DE/

CYGENE LABORATORIES INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2002 2001-04-01 – 2002-03-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation